| | ||||
 |
|
|||
 >4x |
Module 301 |
| General Properties | |
|---|---|
| Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module. | |
| Num gene sets: | 9 |
| Num genes: | 161 (see 838 additional genes for this module) |
| Num experiments: | 351 (133 induced, 218 repressed) |
| Parent module: | 361 |
| Children modules: | 237 238 |
| Gene sets | |
|---|---|
| Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates. | |
| Alizadeh00 27 | |
| Rosenwald01 42 | |
| Alizadeh00 13 | |
| Rosenwald01 31 | |
| Rosenwald01 9 | |
| Alizadeh00 18 | |
| Rosenwald01 48 | |
| Alizadeh00 11 | |
| Rosenwald01 40 | |
| Enriched clinical annotations | |||||||
|---|---|---|---|---|---|---|---|
| For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched. | |||||||
| Clinical annotation | Category | P-value | Hits | Hits(%) | Module hits in category | Arrays in annotation | Arrays |
| Lymphocytes (B lymphoma*) | B lymphoma* | 6.2e-43 | 80 | 60.1 | 133 | 244 | 1945 |
| B cells (B lymphoma*) | B lymphoma* | 1.1e-42 | 78 | 58.6 | 133 | 231 | 1945 |
| Cancer (B lymphoma*) | B lymphoma* | 6.5e-33 | 65 | 48.8 | 133 | 200 | 1945 |
| Hematologic cancer (B lymphoma*) | B lymphoma* | 6.5e-33 | 65 | 48.8 | 133 | 200 | 1945 |
| Cancer and cell line (B lymphoma*) | B lymphoma* | 6.6e-32 | 66 | 49.6 | 133 | 214 | 1945 |
| Hematologic cancer and cell line (B lymphoma*) | B lymphoma* | 6.6e-32 | 66 | 49.6 | 133 | 214 | 1945 |
| Chronic lymphocytic leukemia (B lymphoma) | B lymphoma | 2.7e-28 | 46 | 57.5 | 80 | 46 | 245 |
| Leukemia (B lymphoma) | B lymphoma | 2.7e-28 | 46 | 57.5 | 80 | 46 | 245 |
| Leukemia or leukemia cell line (B lymphoma) | B lymphoma | 2.7e-28 | 46 | 57.5 | 80 | 46 | 245 |
| Hematologic cancer and cell line (Stimulated PBMC) | Stimulated PBMC | 1.1e-26 | 30 | 76.9 | 39 | 30 | 182 |
| Macrophages (Stimulated PBMC) | Stimulated PBMC | 1.1e-26 | 30 | 76.9 | 39 | 30 | 182 |
| Lymphocytes (B lymphoma*) | B lymphoma* | 1.9e-22 | 79 | 36.2 | 218 | 244 | 1945 |
| Cancer and cell line (B lymphoma*) | B lymphoma* | 1.2e-20 | 71 | 32.5 | 218 | 214 | 1945 |
| Hematologic cancer and cell line (B lymphoma*) | B lymphoma* | 1.2e-20 | 71 | 32.5 | 218 | 214 | 1945 |
| B cells (B lymphoma*) | B lymphoma* | 4.2e-17 | 69 | 31.6 | 218 | 231 | 1945 |
| Cancer (B lymphoma*) | B lymphoma* | 1.3e-13 | 58 | 26.6 | 218 | 200 | 1945 |
| Hematologic cancer (B lymphoma*) | B lymphoma* | 1.3e-13 | 58 | 26.6 | 218 | 200 | 1945 |
| Diffuse large B cell lymphoma tumor or cell line (B lymphoma) | B lymphoma | 2.5e-09 | 65 | 81.2 | 80 | 134 | 245 |
| Cell line (Breast cancer) | Breast cancer | 7.1e-07 | 13 | 68.4 | 19 | 30 | 152 |
| Breast cancer cell line (Breast cancer) | Breast cancer | 8.7e-07 | 10 | 52.6 | 19 | 17 | 152 |
| Acute myelogeous leukemia (Leukemia) | Leukemia | 2.0e-06 | 22 | 73.3 | 30 | 50 | 141 |
| Lymphoma or lymphoma cell line (B lymphoma) | B lymphoma | 2.2e-06 | 70 | 87.5 | 80 | 167 | 245 |
| Cell line (B lymphoma) | B lymphoma | 2.4e-06 | 13 | 16.2 | 80 | 14 | 245 |
| Diffuse large B cell lymphoma - DLBCL (B lymphoma) | B lymphoma | 3.1e-06 | 58 | 72.5 | 80 | 126 | 245 |
| Female hormonal cancer cell line (Breast cancer) | Breast cancer | 3.3e-06 | 9 | 47.3 | 19 | 15 | 152 |
| Activated B like DLBCL (B lymphoma) | B lymphoma | 8.4e-06 | 21 | 26.2 | 80 | 30 | 245 |
| Hematologic samples and cell lines (Stimulated PBMC*) | Stimulated PBMC* | 1.9e-05 | 39 | 17.8 | 218 | 182 | 1945 |
| Monocytes (Stimulated PBMC*) | Stimulated PBMC* | 1.9e-05 | 39 | 17.8 | 218 | 182 | 1945 |
| GC B like DLBCL (B lymphoma) | B lymphoma | 0.0001 | 29 | 36.2 | 80 | 53 | 245 |
| Medulloblastoma (Various tumors) | Various tumors | 0.0001 | 5 | 29.4 | 17 | 7 | 154 |
| B. petrussis stimulated immune cells (Stimulated PBMC) | Stimulated PBMC | 0.0001 | 23 | 76.6 | 30 | 67 | 144 |
| Acute leukemia (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Cancer and cell line (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Cancer (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Hematologic cancer and cell line (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Hematologic cancer (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Hematologic samples and cell lines (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Leukemia (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Leukemia or leukemia cell line (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| Monocytes (Leukemia*) | Leukemia* | 0.0002 | 30 | 13.7 | 218 | 141 | 1945 |
| B. petrussis 537 stimulated immune cells (Stimulated PBMC) | Stimulated PBMC | 0.0002 | 5 | 16.6 | 30 | 5 | 144 |
| B. petrussis A2 stimulated immune cells (Stimulated PBMC) | Stimulated PBMC | 0.0002 | 5 | 16.6 | 30 | 5 | 144 |
| B. petrussis Tox 6 stimulated immune cells (Stimulated PBMC) | Stimulated PBMC | 0.0002 | 5 | 16.6 | 30 | 5 | 144 |
| Stimulated immune cells (Stimulated PBMC*) | Stimulated PBMC* | 0.0003 | 30 | 13.7 | 218 | 143 | 1945 |
| Liver cancer cell line (Liver cancer) | Liver cancer | 0.0003 | 4 | 44.4 | 9 | 10 | 207 |
| CNS cancer or cell line (Various tumors) | Various tumors | 0.0003 | 7 | 41.1 | 17 | 16 | 154 |
| CNS tumor (Various tumors) | Various tumors | 0.0003 | 7 | 41.1 | 17 | 16 | 154 |
| Enriched GO annotations | ||||||
|---|---|---|---|---|---|---|
| For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column). | ||||||
| GO annotation | P-value | Hits | Hits(%) | Module genes | Genes in annotation | Genes |
| interleukin binding | 0.0001 | 4 | 8.3 | 48 | 25 | 4566 |
| Visual display | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets. | |||||||||
| You can also view the images within GeneXPress by loading the module gxp file file. | |||||||||
|
|||||||||
